Abstract:Although depression has been studied for many decades, the exact mechanisms that lead to depression are still unknown, and available treatments only help a fraction of patients. In the 1960s, the serotonin hypothesis was published, suggesting that serotonin is the key player in depression. However, this hypothesis is being increasingly doubted. In this review, we aim to contribute to the ongoing debate on the involvement of serotonin in depression. We review the evolution of antidepressant treatments, systemic research over the years, and future research applications that will help to bridge the gap between systemic research and neurotransmitter dynamics using biosensors. Depression is one of the most common psychiatric disorders worldwide, affecting approximately 280 million people, with probably much higher unrecorded cases. Depression is associated with symptoms such as anhedonia, feelings of hopelessness, sleep disturbances, and even suicidal thoughts. Tragically, more than 700 000 people commit suicide each year. Although depression has been studied for many decades, the exact mechanisms that lead to depression are still unknown, and available treatments only help a fraction of patients. In the late 1960s, the serotonin hypothesis was published, suggesting that serotonin is the key player in depressive disorders. However, this hypothesis is being increasingly doubted as there is evidence for the influence of other neurotransmitters, such as noradrenaline, glutamate, and dopamine, as well as larger systemic causes such as altered activity in the limbic network or inflammatory processes. In this narrative review, we aim to contribute to the ongoing debate on the involvement of serotonin in depression. We will review the evolution of antidepressant treatments, systemic research on depression over the years, and future research applications that will help to bridge the gap between systemic research and neurotransmitter dynamics using biosensors. These new tools in combination with systemic applications, will in the future provide a deeper understanding of the serotonergic dynamics in depression.

Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression

Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression

Review—Electrochemical Immunosensors for Depression Markers Detection: Development in Recent Years

Electrochemical Chemically Based Sensors and Emerging Enzymatic Biosensors for Antidepressant Drug Detection: A Review

Advances in biosensors for major depressive disorder diagnostic biomarkers

A Critical Review of Carbon Quantum Dots: From Synthesis toward Applications in Electrochemical Biosensors for the Determination of a Depression-Related Neurotransmitter

Recent Progress in Biosensors for Depression Monitoring—Advancing Personalized Treatment

Real-Time Monitoring of Neurotransmitters in the Brain of Living Animals

Advances in Optogenetic Studies of Depressive-Like Behaviors and Underlying Neural Circuit Mechanisms

Advancements in Brain Research: The In Vivo/In Vitro Electrochemical Detection of Neurochemicals

Optogenetic and chemogenetic insights into the neurocircuitry of depression‐like behaviour: A systematic review

Biosensors for psychiatric biomarkers in mental health monitoring

Pushing the Frontiers: Tools for Monitoring Neurotransmitters and Neuromodulators.

Genetically Encoded Sensors for the in Vivo Detection of Neurochemical Dynamics.

Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression

Selectively Probing Neurochemicals in Living Animals with Electrochemical Systems

Advances In Electrochemical Biosensors For In Vivo Analysis

In Vivo Pharmacodynamic Evaluation of Antidepressants Based on Flux Mitochondrial Cys in Living Mice Via Near Infrared Fluorescence Imaging.

Molecular Biological Aspects of Depressive Disorders: A Modern View

The role of serotonin in depression—A historical roundup and future directions

Non-coding RNAs in Depression: Promising Diagnostic and Therapeutic Biomarkers